Hospital-Acquired Disease Testing Market (Updated Version Available)

Overview Of Hospital-Acquired Disease Testing Market

Hospital acquired infections/diseases (HAIs) or nosocomial infections  are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision. The new market research report Hospital-Acquired Disease Testing Market to its huge collection of research reports. Hospital-Acquired Disease Testing market and delivers a comprehensive individual analysis on the top companies, including Diatherix Laboratories, Gen-Probe, Qiagen, F. Hoffmann-La Roche, Cepheid, Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion

The global Hospital-Acquired Disease Testing market is estimated to be valued at USDXX Million in the year 2028, growing at a CAGR of XX% in the period 2021 to 2028.

The Hospital-Acquired Disease Testing market report offers in-depth and extensive analysis of the factors affecting Market Dynamics, Distribution Channel, Product type, and geography, emerging technological trends, market challenges, recent industrial policies, and market size, revenue share and detailed forecasts during 2021-2028. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the revenue forecasts for global, regional and country levels.

Key Companies
Diatherix Laboratories

Gen-Probe

Qiagen

F. Hoffmann-La Roche

Cepheid

Life Technologies Corporation

Meridian Biosciences

Cantel Medical Corporation

Nordion

Market Product Type Segmentation
UTI Testing

SSI Testing

Pneumococcal Infections Testing

Bloodstream Infections Testing

MRSA Testing

Market by Application Segmentation
Small and Medium Sized Hospitals

Large Sized Hospitals

By Region
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America [United States, Canada, Mexico]
Middle East & Africa [GCC, North Africa, South Africa]
South America [Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the size of occupied by the prominent leaders for the forecast period, 2021 to 2028?
• What will be the share and the growth rate of the Hospital-Acquired Disease Testing market during the forecast period?
• What are the future prospects for the Hospital-Acquired Disease Testing industry in the coming years?
• Which trends are likely to contribute to the development rate of the industry during the forecast period, 2021 to 2028?
• What are the future prospects of the Hospital-Acquired Disease Testing industry for the forecast period, 2021 to 2028?
• Which companies are dominating the competitive landscape across different region and what strategies have they applied to gain a competitive edge?
• What are the major factors responsible for the growth of the market across the different regions?
• What are the challenges faced by the companies operating in the Hospital-Acquired Disease Testing market?

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.